|
Bill & Melinda Gates Foundation announces $200 million grant to accelerate research on "grand challenges" in global health Grants to help overcome scientific roadblocks in AIDS, malaria, other diseases
DAVOS, Switzerland -- The Bill & Melinda
Gates Foundation today announced a $200 million grant to
establish the Grand Challenges in Global Health initiative,
a major new effort and partnership with the National Institutes
of Health (NIH). The initiative will identify critical scientific
challenges in global health and increase research on diseases
that cause millions of deaths in the developing world. Today
only 10 percent of medical research is devoted to the diseases
that cause 90 percent of the health burden in the world,
according to the Global Forum on Health Research.
"There is great potential for science
and technology to solve persistent global health challenges,
but far greater resources are needed," said Bill Gates,
co-founder of the Bill & Melinda Gates Foundation. "This
initiative is about discovery and invention. It is about
finding specific solutions to the hardest problems. By accelerating
research to overcome scientific obstacles in AIDS, malaria,
and other diseases, millions of lives could be saved."
Gates announced the initiative today at the World Economic
Forum's annual meeting in Davos, Switzerland, where he participated
in a panel discussion on "Science for the Global Good."
The new initiative will be administered by the Foundation
for the National Institutes of Health (FNIH). The NIH also
has agreed to provide scientific advice, expertise, and
support. "This groundbreaking public-private partnership
between the National Institutes of Health, the Foundation
for the National Institutes of Health, and the Bill & Melinda
Gates Foundation is an ideal complement to the NIH's efforts
to improve global health," said Dr. Elias Zerhouni, Director
of the National Institutes of Health. "With our respective
partners, we will strive to create an unprecedented synergy,
focused on engaging the best scientific minds of our time,
maximizing the impact of our respective resources, and thus
spurring creativity and innovation in this field for the
ultimate benefit of all humankind." As a partner in
this new initiative, the NIH will identify activities that
are appropriate for government funding. Possibilities include
the parallel release of announcements to fund joint or associated
projects, funding shared resources and training, and announcing
funding opportunities for follow-up grants that complement
the Grand Challenges in Global Health initiative.
Harold Varmus
to Chair Scientific Board
Nobel
Laureate Dr. Harold Varmus, President of the Memorial Sloan-Kettering
Cancer Center in New York and former Director of the National
Institutes of Health, will chair a board of preeminent scientists
who will guide and direct the initiative.
Other
experts who have agreed to participate on the board include:
Drs. Roy Anderson, Head of the Department of Infectious
Disease Epidemiology at the Imperial College of the University
of London; Anthony Fauci, Director of the U.S. National
Institute of Allergy and Infectious Diseases; Nirmal Ganguly,
Director General of the Indian Council for Medical Research;
Julie Gerberding, Director of the U.S. Centers for Disease
Control; Richard D. Klausner, Executive Director of the
Global Health Program at the Bill & Melinda Gates Foundation;
Francis Nkrumah, Director of the Noguchi Memorial Institute
for Medical Research at the University of Ghana; and Elias
Zerhouni, Director of the U.S. National Institutes of Health.
The
scientific board will identify and publish a focused set
of critical problems, or "grand challenges," in global health,
that--if solved--could lead to important advances against
diseases of the developing world. The initiative will then
provide competitive grants to teams of scientists around
the world to search for solutions to each of the challenges.
"We
live in an era of incredible innovation in science and technology,
particularly in the area of medical research," said Dr.
Richard Klausner, executive director of the foundation's
global health program. "What's needed now is new funding
to support scientists to articulate and prioritize great
scientific challenges, and encourage novel research approaches.
It is our hope that this will spur a new field of endeavor
called global health science."
With
input from scientists and public health leaders from around
the world, the scientific board will identify the list of
challenges. Examples of potential challenges to be considered
include:
- Finding novel approaches to preventing and treating HIV
- Identifying an "Achilles heel" to block reactivation of latent TB
- Investigating ways to make mosquitoes incapable of transmitting diseases such as malaria, dengue, and West Nile
- Finding innovative approaches to protecting children from life-threatening
diarrhea and respiratory infections
- Identifying vehicles to deliver combinations of micronutrients to optimize child nutrition, cognition, and survival
The specific objectives of the initiative are to:
- Articulate a set of critical challenges that the grants ultimately will address
- Speed the creation of solutions to these critical challenges
- Focus scientific attention on the most important diseases of the developing world
- Support the most creative and innovative researchers throughout the world, developing solutions to bottlenecks caused by lack of knowledge, technology, or other challenges
- Create communities of researchers working towards measurable outcomes
- Raise the level of engagement of the scientific community, both public and private, around these challenges in global health
Grant proposals for up to $20 million to be invited this summer
The scientific board
will publish the agreed-upon scientific challenges this
summer, and the FNIH will issue a request for applications
(RFA) for research projects to investigate them. Grants
of up to $20 million will be awarded.
While
individual submissions will be entertained, the RFA will
emphasize the importance of consortia--cross-discipline
integration across programs, organizations, and institutions--in
proposing the most innovative research and development approaches.
The
Bill & Melinda Gates Foundation is dedicated to improving
people's lives by sharing advances in health and learning
with the global community. Led by Bill Gates' father, William
H. Gates, and Patty Stonesifer, the Seattle-based foundation
has an endowment of approximately $24 billion.
The
National Institutes of Health (NIH) is the premier medical
research organization in the world. Directing most of the
U.S. government's investment in medical research, NIH leads
the way toward important medical discoveries that improve
people's health and save lives. NIH investigates the causes,
treatments, and cures for both common and rare diseases.
Composed of 27 Institutes and Centers, each with its own
broadly defined mission, NIH provides leadership and financial
support to researchers in every state and throughout the
world.
The
Foundation for the National Institutes of Health (FNIH)
builds and fosters collaborative relationships with philanthropy,
industry, and academia to support the mission of the National
Institutes of Health--improving health through scientific
discovery. FNIH is a non-profit, 501(c)3 corporation authorized
by and established at the direction of the United States
Congress.
On the Internet:
Bill & Melinda Gates Foundation, www.gatesfoundation.org
National Institutes of Health, www.nih.gov
Foundation for the National Institutes of Health, www.fnih.org
|
 |